SCHEMBL28500481

SCHEMBL28500481

NC(=O)O[C@H](CO)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
PKM P14618 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ADRB1 P08588 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2B P41595 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
LMNA P02545 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
EDNRB P24530 1/20 0.44
MAPK1 P28482 1/20 0.44
MC4R P32245 1/20 0.44
CYP2C19 P33261 1/20 0.44
DRD3 P35462 1/20 0.44
MC3R P41968 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6330737 1.00 GSR (0.51) GSRCYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL1043546 1.00 GSR (0.51) GSRCYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL28552915 0.85 ADRB1 (0.49) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL22813473 0.85 ADRB1 (0.49) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL7511466 0.85 CYP1A2 (0.50) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL21523061 0.85 CYP1A2 (0.50) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL28766159 0.85 CYP1A2 (0.50) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL2836232 0.84 GSR (0.55) GSRCYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL27811982 0.83 ADRB1 (0.45) ADRB1HTR2AHTR2BSIGMAR1
SCHEMBL514164 0.83 CYP1A2 (0.49) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118239948-A Solid forms and methods of making fused tricyclic compounds, including methods of use thereof 豪夫迈·罗氏有限公司 2024-06-25 CN disclosed
CN-117946107-A Solid forms and methods of making fused tricyclic compounds, including methods of use thereof 豪夫迈·罗氏有限公司 2024-04-30 CN disclosed
CN-115916790-A Pyrido [2,3-b ] [1,4] oxazines or tetrahydropyrido [2,3-b ] [1,4] oxazepines as IAP antagonists 百济神州有限公司 2023-04-04 CN disclosed
CN-112437685-A Solid forms of 3- ((1R,3R) -1- (2, 6-difluoro-4- ((1- (3-fluoropropyl) azetidin-3-yl) amino) phenyl) -3-methyl-1, 3,4, 9-tetrahydro-2H-pyrido [3,4-b ] indol-2-yl) -2, 2-difluoropropan-1-ol and methods of making fused tricyclic compounds containing a substituted phenyl or pyridinyl moiety, including methods of use thereof 豪夫迈·罗氏有限公司 2021-03-02 CN disclosed
CN-107074887-B Substituted dihydropyrrolopyrazoles 宇部兴产株式会社 2020-12-22 CN disclosed